Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.
As discussed during Diabetes Technology Roundtable V, recent studies evaluating safety and effectiveness of a tubeless AID system in patients with type 1 diabetes demonstrated: